| Pfizer AG - Talzenna 0.5 mg, Hartkapseln | | 67141 | | 05 | | Talzenna 0.5 mg | | Hartkapseln | | L01XK04 | | Talazoparib | | 12.07.2024 | | |
| | Composition | | talazoparibum 0.5 mg ut talazoparibi tosilas, cellulosum microcristallinum silicificatum, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Talazoparibum | 0.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Talazoparibum | 0.5 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Ammonii Hydroxidum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Pro Capsula | | | | Propylenglycol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 009 | 30 | 2646.97 | 2895.15 | A | SL | No |
|
|
